GoFast CD19 CAR-T cell therapy
/ Chinese PLA General Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 27, 2026
GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: Chinese PLA General Hospital
New P1 trial • B Cell Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 1
Of
1
Go to page
1